01.08.2013 | Correspondence
Harm associated with 6 % tetrastarch 130 kDa [hydroxyethyl starch (HES) 130/0.4 and 130/0.42] is robust to sensitivity analysis by excluding Dolecek et al.
Erschienen in: Intensive Care Medicine | Ausgabe 8/2013
Einloggen, um Zugang zu erhalten